While there are some signs stocks are nearing a capitulation stage, it has not given the all clear to get back in yet, reports Joe Duarte.
There may be some bargains lurking on the market carnage of the last month, reports Joe Duarte.
No matter what, you can’t go wrong with lots of cash as there is no clear bottom in sight, writes Joe Duarte.
Gilead Sciences’ antiviral drug remdesivir is no vaccine, but it could help treat the Coronavirus while one is being developed, reports Joe Duarte.
Its too soon to say this massive sell-off is over, but it is not too soon to make plans for profiting from the aftermath, reports Joe Duarte.
Will the Fed act to protect markets, and more importantly, will it have any impact, asks Joe Duarte.
With markets taking it on the chin, Joe Duarte has a sweet alternative that could climb the wall of worry.
Several technical indicators turned soft last week, and the Fed has reduced its support through the repo market, notes Joe Duarte.
The Coronavirus has highlighted the value of the biotech sector working on creating vaccines for various threats, writes Joe Duarte.
The Stock market is clearly on pins and needles as traders weigh the unknown repercussions of the Coronavirus against the Federal Reserve’s bipolar actions regarding liquidity in the repo market.
Is there a cure for the Coronavirus, perhaps, and it could shake up markets, writes Joe Duarte.
Is the stock market about to crash? The question is certainly coming up a lot these days, writes Joe Duarte.
Markets are navigating various risks, investors need to manage risk, writes Joe Duarte.
While chaos appears to be rising, watch these three bellwether stocks for where the broad market is headed, reports Joe Duarte.
We may be entering the edge of chaos for markets, reports Joe Duarte.
The stock market may continue to make higher highs on a regular basis as long as the Federal Reserve continues to pump money into the Repo markets, forecasts Dr. Joe Duarte, editor of In the Money Options.
There has been a lot of talk about the length of the current bull market and the probabilities of a correction or worse.
The stock market may continue to make higher highs on a regular basis as long the Federal Reserve continues to pump money into the Repo markets
In 2019, Dr. Joe Duarte, editor of In the Money Options, selected Texas Instruments (TXN) as his Top Pick; the stock has risen 37%. He now highlights a healthcare insurer as a favorite conservative idea for the coming year.
While stocks continue to perform, there are risk out there, particularly if the Fed drains abandons its repo operations, notes Joe Duarte.